Novartis to slash nearly 2,000 U.S. jobs
by on Jan.13, 2012, under Health and Fitness
ZURICH (Reuters) – Novartis AG is cutting nearly 2,000 jobs in the United States ahead of the patent loss of top-selling blood pressure drug Diovan as it braces for tough market conditions and a slump in sales of another key drug. Novartis is the …
View full post on Yahoo! Health News
